Skip to main content

EL PAPEL CAUSAL DEL SELENIO EN LA DIABETES: UN ESTUDIO OMICO PARA INFORMAR A LA MEDICINA DE PRECISION

PID2019-108973RB-C22

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSITAT DE VALÈNCIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Metabolomic patterns, redox-related genes and metals, and bone fragility endpoints in the Hortega Study

  • Galvez-Fernandez, Marta
  • Rodríguez-Hernández, Zulema
  • Grau-Perez, Maria
  • Chaves, F. Javier
  • García-García, Ana Bárbara
  • Amigo, Nuria
  • Monleón, Daniel
  • Garcia-Barrera, Tamara
  • Gomez-Ariza, Jose L.
  • Briongos-Figuero, Laisa S.
  • Perez-Castrillon, Jose L.
  • Redón, Josep
  • Tellez-Plaza, Maria
  • Martin-Escudero, Juan C.
[EN] Background: The potential joint influence of metabolites on bone fragility has been rarely evaluated. We assessed the association of plasma metabolic patterns with bone fragility endpoints (primarily, incident osteoporosisrelated bone fractures, and, secondarily, bone mineral density BMD) in the Hortega Study participants. Redox balance plays a key role in bone metabolism. We also assessed differential associations in participant subgroups by redox-related metal exposure levels and candidate genetic variants. Material and methods: In 467 participants older than 50 years from the Hortega Study, a representative sample from a region in Spain, we estimated metabolic principal components (mPC) for 54 plasma metabolites from NMR-spectrometry. Metals biomarkers were measured in plasma by AAS and in urine by HPLC-ICPMS. Redoxrelated SNPs (N = 341) were measured by oligo-ligation assay. Results: The prospective association with incident bone fractures was inverse for mPC1 (non-essential and essential amino acids, including branched-chain, and bacterial co-metabolites, including isobutyrate, trimethylamines and phenylpropionate, versus fatty acids and VLDL) and mPC4 (HDL), but positive for mPC2 (essential amino acids, including aromatic, and bacterial co-metabolites, including isopropanol and methanol). Findings from BMD models were consistent. Participants with decreased selenium and increased antimony, arsenic and, suggestively, cadmium exposures showed higher mPC2-associated bone fractures risk. Genetic variants annotated to 19 genes, with the strongest evidence for NCF4, NOX4 and XDH, showed differential metabolic-related bone fractures risk. Conclusions: Metabolic patterns reflecting amino acids, microbiota co-metabolism and lipid metabolism were associated with bone fragility endpoints. Carriers of redox-related variants may benefit from metabolic interventions to prevent the consequences of bone fragility depending on their antimony, arsenic, selenium, and, possibly, cadmium, exposure levels., Funding statement The work was funded by theo State Research Agency at the Ministerio de Ciencia Innovacion y Universidades of Spain (PID2019-108973RB-C21, PID2019-108973RB-C22 and PCIN-2017-117) ; the Generalitat Valenciana of Spain (IDIFEDER/2021/072, GRUPOS 03/101, PROMETEO/2009/029, ACOMP/2013/039, IDIFEDER/2021/072 and GRISOLIAP/2021/119) ; the EU Joint Programming Initiative Healthy Diet Healthy Life (HDHL) GUTMOM (INTIMIC-085) ; the Strategic Action for Research in Health sciences [CP12/03080, PI15/00071, PI10/0082, PI13/01848, PI14/00874, PI16/01402, PI17/00544 and PI11/00726] ; CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN) (CIBER-02-08-2009, CB06/03 and CB12/03/30016) ; the Castilla-Leon Government (GRS/279/A/08) and European Network of Excellence Ingenious Hypercare (EPSS-037093) from the European Commission. The Strategic Action for Research in Health sciences and CIBEROBN are initiatives from Carlos III Health Institute Madrid and co-funded with European Funds for Regional Development (FEDER) . M.G-P received the support of a fellowship from "la Caixa" Foundation (ID 100010434, fellowship code LCF/BQ/IN18/11660001) . The funding bodies had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publication Artículo científico (JournalArticle)

Gene-environment interaction analysis of redox-related metals and genetic variants with plasma metabolic patterns in a general population from Spain: The Hortega Study

  • Galvez-Fernandez, Marta
  • Domingo-Relloso, Arce
  • Rodríguez-Hernández, Zulema
  • Gonzalez-Marrachelli, Vannina
  • Grau-Perez, Maria
  • Morales-Tatay, José M.
  • Amigo, Nuria
  • Garcia-Barrera, Tamara
  • Gomez-Ariza, Jose L.
  • Chaves, F. Javier
  • Garcia-Garcia, Ana Barbara
  • Melero, Rebeca
  • Tellez-Plaza, Maria
  • Sanchez Saez, Francisco|||0000-0002-3011-9884
  • Tarazona, Sonia|||0000-0001-5346-1407
[EN] Background: Limited studies have evaluated the joint influence of redox-related metals and genetic variation on metabolic pathways. We analyzed the association of 11 metals with metabolic patterns, and the interacting role of candidate genetic variants, in 1145 participants from the Hortega Study, a population-based sample from Spain. Methods: Urine antimony (Sb), arsenic, barium (Ba), cadmium (Cd), chromium (Cr), cobalt (Co), molybdenum (Mo) and vanadium (V), and plasma copper (Cu), selenium (Se) and zinc (Zn) were measured by ICP-MS and AAS, respectively. We summarized 54 plasma metabolites, measured with targeted NMR, by estimating metabolic principal components (mPC). Redox-related SNPs (N = 291) were measured by oligo-ligation assay. Results: In our study, the association with metabolic principal component (mPC) 1 (reflecting non-essential and essential amino acids, including branched chain, and bacterial co-metabolism versus fatty acids and VLDL subclasses) was positive for Se , Zn, but inverse for Cu, arsenobetaine-corrected arsenic (As) and Sb. The association with mPC2 (reflecting essential amino acids, including aromatic , bacterial co-metabolism) was inverse for Se, Zn and Cd. The association with mPC3 (reflecting LDL subclasses) was positive for Cu, Se and Zn, but inverse for Co. The association for mPC4 (reflecting HDL subclasses) was positive for Sb, but inverse for plasma Zn. These associations were mainly driven by Cu and Sb for mPC1; Se, Zn and Cd for mPC2; Co, Se and Zn for mPC3; and Zn for mPC4. The most SNP-metal interacting genes were NOX1, GSR, GCLC, AGT and REN. Co and Zn showed the highest number of interactions with genetic variants associated to enriched endocrine, car-diovascular and neurological pathways. Conclusions: Exposures to Co, Cu, Se, Zn, As, Cd and Sb were associated with several metabolic patterns involved in chronic disease. Carriers of redox-related variants may have differential susceptibility to metabolic alterations associated to excessive exposure to metals., This work was supported by the Strategic Action for Research in Health sciences [CP12/03080, PI15/00071, PI10/0082, PI13/01848, PI14/00874, PI16/01402, PI21/00506 and PI11/00726] , CIBER Fisio-patologia Obesidad y Nutricion (CIBEROBN) (CIBER-02-08-2009, CB06/03 and CB12/03/30,016) , the State Agency for Research (PID2019-108973RB-C21 and C22) , the Valencia Government (GRU-POS 03/101; PROMETEO/2009/029 and ACOMP/2013/039, IDI-FEDER/2021/072 and GRISOLIAP/2021/119) , the Castilla-Leon Government (GRS/279/A/08) and European Network of Excellence Ingenious Hypercare (EPSS-037093) from the European Commission. The Strategic Action for Research in Health sciences, CIBERDEM and CIBEROBN are initiatives from Carlos III Health Institute Madrid and co-funded with European Funds for Regional Development (FEDER) . The State Agency for Research and Carlos III Health Institute belong to the Spanish Ministry of Science and Innovation. ADR received the support of a fellowship from "la Caixa"Foundation (ID 100010434) (fellowship code "LCF/BQ/DR19/11740016") . MGP received the support of a fellowship from "la Caixa" Foundation (ID 100010434, fellowship code LCFLCF/BQ/DI18/11660001) . The funding bodies had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Selenium and impaired physical function in US and Spanish older adults

  • García-Esquinas, E.
  • Carrasco-Rios, M.
  • Ortolá, R.
  • Sotos Prieto, M.
  • Pérez-Gómez, Beatriz
  • Gutiérrez-González, E.
  • Banegas, José Ramón
  • Queipo, R.
  • Omedo, P.
  • Gil, F.
  • Tellez-Plaza, M.
  • Navas-Acien, Ana
  • Pastor-Barriuso, Roberto
  • Rodriguez-Artalejo, Fernando
[Background]: Selenium (Se) is a trace element with a narrow safety margin., [Objectives]: To evaluate the cross-sectional and longitudinal dose-response association between Se exposure and measures of impaired physical function and disability in older adults., [Design]: NHANES 2011–2014 cross-sectional (US, n = 1733, age ≥60 years) and Seniors-ENRICA-2 2017–2019 cross-sectional and longitudinal (Spain, n = 2548 and 1741, respectively, age ≥65 years) data were analyzed. Whole blood and serum Se levels were measured using inductively coupled plasma-mass spectrometry. Lower-extremity performance was assessed with the Short Physical Performance Battery, and muscle weakness with a dynamometer. Incident mobility and agility limitations, and disability in instrumental activities of daily living (IADL) were ascertained with standardized questionnaires. Analyses were adjusted for relevant confounders, including physical activity. Results across studies were pooled using random-effects meta-analysis., [Results]: Meta-analyzed odds ratios (95% confidence interval) per log2 increase in whole blood Se were 0.54 (0.32; 0.76) for weakness, 0.59 (0.34; 0.83) for impaired lower-extremity performance, 0.48 (0.31; 0.68) for mobility limitations, 0.71 (0.45; 0.97) for agility limitations, and 0.34 (0.12; 0.56) for disability in at least one IADL. Analyses for serum Se in NHANES showed similar results. Findings suggest the inverse association with grip strength is progressive below 140 μg/L (p-value for non-linear trend in the Seniors-ENRICA-2 study = 0.13), and above 140 μg/L (p-value for non-linear trend in NHANES = 0.11). In the Seniors-ENRICA-2 cohort, with a 2.2 year follow-up period, a doubling in baseline Se levels were associated with a lower incidence of weakness [odds ratio (95% confidence interval): 0.45 (0.22; 0.91)], impaired lower-extremity performance [0.63 (0.32; 1.23)], mobility [0.43 (0.21; 0.91)] and agility [0.38 (0.18; 0.78)] limitations., [Discussion]: In US and Spanish older adults, Se concentrations were inversely associated with physical function limitations. Further studies are needed to elucidate underlying mechanisms., This work has been supported by grants PI18/287 and 16/609 from the Instituto de Salud Carlos III, State Secretary of R + D + I, and FEDER/FSE; and by PID2019-108973RB-C21/C22 from the State Secretary of R + D + I., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Metabolic effects of early life stress and pre-pregnancy obesity are long lasting and sex specific in mice

  • Brix, Lea M
  • Monleon, Daniel
  • Collado, María Carmen
  • Ederveen, Thomas H A
  • Toksöz, Irmak
  • Bordes, Joeri
  • van Doeselaar, Lotte
  • Engelhardt, Clara
  • Mitra, Shiladitya
  • Narayan, Sowmya
  • Schmidt, Mathias V
Early life stress (ELS) is associated with metabolic, cognitive, and psychiatric diseases and has a very high prevalence, highlighting the urgent need for a better understanding of the versatile physiological changes and identification of predictive biomarkers. In addition to programming the hypothalamic-pituitary-adrenal (HPA) axis, ELS may also affect the gut microbiota and metabolome, opening up a promising research direction for identifying early biomarkers of ELS-induced (mal)adaptation. Other factors affecting these parameters include maternal metabolic status and diet, with maternal obesity shown to predispose offspring to later metabolic disease. The aim of the present study was to investigate the long-term effects of ELS and maternal obesity on the metabolic and stress phenotype of rodent offspring. To this end, offspring of both sexes were subjected to an adverse early-life experience, and their metabolic and stress phenotypes were examined. In addition, we assessed whether a prenatal maternal and an adult high-fat diet (HFD) stressor further shape observed ELS-induced phenotypes. We show that ELS has long-term effects on male body weight (BW) across the lifespan, whereas females more successfully counteract ELS-induced weight loss, possibly by adapting their microbiota, thereby stabilizing a balanced metabolome. Furthermore, the metabolic effects of a maternal HFD on BW are exclusively triggered by a dietary challenge in adult offspring and are more pronounced in males than in females. Overall, our study suggests that the female microbiota protects against an ELS challenge, rendering them more resilient to additional maternal- and adult nutritional stressors than males., This work was supported by the “GUTMOM” grant of the ERA-Net Cofund HDHL-INTIMIC (INtesTInal MIcrobiomics) under the JPI HDHL (Joint Programming Initiative – A healthy diet for a healthy life) umbrella (01EA1805; MVS), the SCHM2360-5-1 grant (MVS) from the German Research Foundation (DFG), the ZonMw grant from the Netherlands Organisation for Health Research and Development (project number 529051019), the DIM-ELI-2 grant of La Fundación La Marató-TV3 (ref. 2018-27/30-31), the PID2019-108973RB-C22 and PCIN2017-117 grants from the Ministerio de Ciencia e Innovación of Spain and the grants GV/2020/048 and IDIFEDER/2021/072 from the Generalitat Valenciana of Spain. Open Access funding enabled and organized by Projekt DEAL., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A mild increase in nutrient signaling to mTORC1 in mice leads to parenchymal damage, myeloid inflammation and shortened lifespan

  • Ortega-Molina, Ana
  • Lebrero-Fernández, Cristina
  • Sanz, Alba
  • Calvo-Rubio, Miguel
  • Deleyto-Seldas, Nerea
  • de Prado-Rivas, Lucía
  • Plata-Gómez, Ana Belén
  • Fernández-Florido, Elena
  • González-García, Patricia
  • Vivas-García, Yurena
  • Sánchez García, Elena
  • Graña-Castro, Osvaldo
  • Price, Nathan L
  • Aroca-Crevillén, Alejandra
  • Caleiras, Eduardo
  • Monleón, Daniel
  • Borrás, Consuelo
  • Casanova-Acebes, María
  • de Cabo, Rafael
  • Efeyan, Alejo
The mechanistic target of rapamycin complex 1 controls cellular anabolism in response to growth factor signaling and to nutrient sufficiency signaled through the Rag GTPases. Inhibition of mTOR reproducibly extends longevity across eukaryotes. Here we report that mice that endogenously express active mutant variants of RagC exhibit multiple features of parenchymal damage that include senescence, expression of inflammatory molecules, increased myeloid inflammation with extensive features of inflammaging and a ~30% reduction in lifespan. Through bone marrow transplantation experiments, we show that myeloid cells are abnormally activated by signals emanating from dysfunctional RagC-mutant parenchyma, causing neutrophil extravasation that inflicts additional inflammatory damage. Therapeutic suppression of myeloid inflammation in aged RagC-mutant mice attenuates parenchymal damage and extends survival. Together, our findings link mildly increased nutrient signaling to limited lifespan in mammals, and support a two-component process of parenchymal damage and myeloid inflammation that together precipitate a time-dependent organ deterioration that limits longevity., ERC-2014-STG-638891/EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) LCF/PR/HR21/0046/"la Caixa" Foundation (Caixa Foundation) ID 100010434 LCF/BQ/DR19/11740022/"la Caixa" Foundation (Caixa Foundation) LABAE16001EFEY/AECC/Fundación Científica Asociación Española Contra el Cáncer (Scientific Foundation, Spanish Association Against Cancer) Research was supported by the RETOS projects Programme of Spanish Ministry of Science,Innovation and Universities, Spanish State Research Agency, co-funded by the European Regional Development Fund (grants PID2019-104012RB-I00 and PID2022-136413OB-I00), EU-H2020 Programme (ERC-2014-STG-638891), a Ramon y Cajal Award from MICIU/AEI (RYC-2013-13546) C.B. and D.M. acknowledge grant PID2020-113839RB-I00 funded by MCIN/AEI/10.13039/501100011033 and grant PID2019-108973RB-C22 funded by MCIN/AEI/10.13039/501100011033, respectively E.F.F. is a PIPF-2022/SAL-GL-24382 fellow from the Autonomous Community of Madrid
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publication Artículo científico (JournalArticle)

Non-genetic and genetic determinants of serum selenium and selenium species in the Aragon Workers Health Study

  • Rodriguez-Hernandez, Zulema
  • Paredes-Douton, Anabel
  • Galvez-Fernandez, Marta
  • Grau-Perez, Maria
  • Sotos-Prieto, Mercedes
  • Rentero-Garrido, Pilar
  • Gonzalez-Estecha, Montserrat
  • Llorente-Ballesteros, Maria Teresa
  • Gomez-Ariza, Jose L.
  • Callejon-Leblic, Belen
  • Fernandez-Navarro, Pablo
  • Laclaustra, Martin
  • Cenarro, Ana
  • Civeira, Fernando
  • Glabonjat, Ronald A.
  • Monleon, Daniel
  • Pastor-Barriuso, Roberto
  • Moreno-Franco, Belen
  • Garcia-Barrera, Tamara
  • Tellez-Plaza, Maria
Understanding potential determinants of selenium biomarkers can help to unravel selenium health effects. We evaluated the contribution of non-genetic (sociodemographic and lifestyle) and genetic factors to serum selenium biomarkers and selenium species (quantified as selenium) including selenium in glutathione peroxidase (GPx), selenoprotein P (SeP), selenoalbumin (SeAlb) and total selenometabolites (Se-metabolites) in the Aragon Workers Health Study (AWHS), a predominantly male cohort of car assembly factory workers in Spain. Total serum selenium and selenium species were measured by HPLC/ICP-QQQ-MS in 1624 AWHS participants. Blood and urine selenium, measured by ICP-MS, were available in a subset. A Healthy Lifestyle Score (HLS) included Mediterranean diet, physical activity, smoking, BMI and alcohol intake. Candidate gene and genome-wide discovery analyses (CGA and GDA, respectively) were based on TOPMed imputed SNPs. In sex and age-adjusted models, overall HLS, physical activity, and specific foods intake showed positive associations with serum total selenium, SeAlb and Se-metabolites concentrations. The associations between smoking status and BMI with total serum selenium; age, smoking status, BMI and meat intake with SeAlb; and smoking status with Se-metabolites, were inverse. In the GDA, we identified 20, 24, 21, 26, 16, 20 and 68 independent genetic loci for serum total selenium, GPx, SeP, SeAlb, Se-metabolites, and total blood and urine selenium, respectively, with some overlapping genes also relevant in the CGA. Enrichment analysis pointed to biological pathways including circadian rhythm regulation, immune system processes, signaling and receptor- and transporter-related pathways. The explained variability of selenium markers ranged from 15 % for SeP to 21 % for SeAlb and from 0.2 % for SeP to 3.5 % for SeAlb in environmental determinants-adjusted models with and without the specific selenium biomarker polygenic score, respectively. While the genetic contribution is substantial, selenium status might be influenced by reinforced healthy lifestyle interventions. Follow-up genetic studies to evaluate selenium health consequences are granted.